Gene networks in neurodegenerative disorders

Area of Science:

• Genomics and Bioinformatics
• Neuroscience
• Molecular Biology

Background:

• Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's disease (AD) exhibit overlapping pathological mechanisms and genetic factors.
• The shared etiology suggests common underlying molecular alterations that may trigger these neurodegenerative conditions.

Purpose of the Study:

• To analyze gene expression data from four microarrays across ALS, PD, and AD.
• To systematically examine seven specific genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25, VSNL1) implicated in these diseases.
• To construct a protein-interaction network for identifying shared pathways, microRNAs (miRNAs), and potential therapeutic drugs.

Main Methods:

• Systematic review and analysis of four gene expression microarrays.
• Network construction using Cytoscape software based on protein interactions of seven key genes.
• Identification of significantly altered pathways, miRNAs, and drugs associated with ALS, PD, and AD.

Main Results:

• The PI3K-Akt signaling pathway was identified as the most significantly affected pathway across the three neurodegenerative diseases.
• Thirteen specific microRNAs (e.g., miRNA-19B1, miRNA-107, miRNA-124) were found to be altered.
• Four drugs (Estradiol, Acetaminophen, Resveratrol, Progesterone) were identified as potential therapeutic candidates.

Conclusions:

• Shared molecular pathways and gene alterations underlie ALS, PD, and AD.
• The identified miRNAs and drugs offer promising avenues for developing novel therapeutic strategies.
• Gene expression analysis provides valuable insights into biomarkers and treatment targets for neurodegenerative diseases.